Operating profit before deduction of amortization: Zenas Biopharma (ZBIO)
Zenas Biopharma Inc leverages global alliances to develop a niche antibody segment, establishing a reputable image as a developer of autoimmune pathology therapies. The change in EBITDA demonstrates the business's ability to generate liquidity, with the parameter value equal to 0.00. However, financial stability is constrained by the lack of recurring revenue and uncertainty regarding the outcomes of clinical trials for new drugs.
Zenas Biopharma (ZBIO) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
- earnings and multiples data:
ZBIO - Net Profit|Projected Future Earnings Zenas Biopharma Inc|ZBIO - Price to Earnings Ratio|Market Cap to Projected Earnings zenasbio.com|ZBIO - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Zenas Biopharma|ZBIO - Operating profit EBITDA|Earnings per share for the last twelve months Zenas Biopharma|ZBIO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months zenasbio.com|ZBIO - Earnings per share growth in current year|Expected net earnings per share growth next year Zenas Biopharma Inc
- sales and revenue indicators:
Fundamental company valuation:Zenas Corp, ZBIO
For Zenas Biopharma Inc (ZBIO), the development of its immunology pipeline and the success of obexelimab determine its financial stability. This indicator measures daily cash flow from core operations before depreciation. This price action reflects the real capital inflow and institutional interest in the biotech firm. The upward trend confirms the effectiveness of a strategy devoid of debt load. By analyzing the level of EBITDA, investors can identify trend reversals in a timely manner.
Who Zenas Biopharma Inc competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization VERA|DNTH: Operating profit EBITDA|Profit before interest, taxes and amortization pharvaris.com (PHVS)|Profit before payment of interest, taxes and amortization AbCellera Biologics Inc.|Operating profit before amortization TRML (Tourmaline Bio Inc)|Operating profit EBITDA PGEN|Operating profit EBITDA Pharming Corp (PHAR)|Profit before payment of interest, taxes and amortization Nektar Therapeutics NKTR|Operating income before deduction of amortization upstreambio.com (UPB)|IMNM: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization GOSS (Gossamer Bio Inc)|KALV: Operating profit EBITDA|SEPN (Septerna Pharma) - Profit before payment of interest, taxes and amortization|PVLA (Pieris Pharmaceuticals) - Operating profit EBITDA|savarapharma.com (SVRA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rigel Pharmaceuticals, Inc. (RIGL)|ANAB - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Astria Pharma ATXS|ENGN (enGene Corp) - Profit before deduction of interest, taxes, depreciation and amortization|RAPT Therapeutics - Operating profit EBITDA|Income before deduction of interest, taxes and amortization JBIO (Aerovate Therapeutics Inc)|ACRS: Operating profit EBITDA|Kyverna Therapeutics Inc. (KYTX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Tiziana Life Sciences PLC|CABA: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Ventyx Biosciences (VTYX)|Operating profit before deduction of amortization theratech.com THTX|Operating profit EBITDA AVTX (Avalo Therapeutics)|Operating profit EBITDA Eledon Pharmaceuticals Inc. ELDN|AGEN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization CLYM (Climb Bio, Inc)|ZURA: Operating profit EBITDA|ATYR - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Adagene Inc|Operating profit before amortization IMA (Ikena Oncology, Inc.)|Operating profit EBITDA STTK|Operating profit before deduction of amortization equilliumbio.com EQ|Connect Biopharma Holdings Limited - Operating profit before deduction of amortization|IMUX (Immunic Therapeutics) - Profit before deduction of interest, taxes, depreciation and amortization|Atara Biotherapeutics Inc - Operating profit EBITDA|IFRX: Profit before payment of interest, taxes and amortization|XFOR: Operating profit EBITDA|ACET - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Celularity Inc|Profit before interest, taxes and amortization inmunebio.com INMB|Profit before payment of interest, taxes and amortization Barinthus Biotherapeutics plc (BRNS)|KZR: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA SABS (SAB Biotherapeutics, Inc)|Income before deduction of interest, taxes and amortization AKTX|Enlivex Therapeutics, Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Edesa Biotech Inc - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization iBio Corp|Operating profit before deduction of amortization Carisma Tx (CARM)|Operating profit EBITDA XTLB|Operating profit EBITDA boltbio.com (BOLT)|HCW Biologics - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech Inc. - Operating profit EBITDA|Operating income before deduction of amortization Aditxt ADTX|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization xortx.com|Profit before payment of interest, taxes and amortization Vyome Holdings|Operating profit before deduction of amortization Revelation Biosciences Inc (REVB)|Operating profit before deduction of amortization INDP (Indaptus)|Operating profit EBITDA BiondVax Pharmaceuticals (SCNI)|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD: Operating profit before amortization|Allakos Therapeutics - Operating profit EBITDA|Profit before interest, taxes and amortization HOOKIPA Pharma Inc.|IGMS (igmbio.com) - Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization ITOS (iTeos Pharma)|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization tcbiopharm.com TCBP|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc. (THRD)
